But David Christensen, director of congressional affairs for the Family Research Council, said Dr. Crawford acted properly in taking time to consider the legal and regulatory issues that go along with this type of dual marketing approval. The implications go beyond Plan B and beyond just scientific considerations, he said. “This wasn't politics,” he said. “This was just prudence.”
News
Testimony: FDA Leaders Put Politics First on Plan B : In a lawsuit, the Center for Reproductive Rights and other groups are seeking over-the-counter access for all.
Publish date: June 15, 2006